These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7579557)

  • 41. Interaction of tubulin and cellular microtubules with the new antitumor drug MDL 27048. A powerful and reversible microtubule inhibitor.
    Peyrot V; Leynadier D; Sarrazin M; Briand C; Rodriquez A; Nieto JM; Andreu JM
    J Biol Chem; 1989 Dec; 264(35):21296-301. PubMed ID: 2592375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemistry and chemical biology of taxane anticancer agents.
    Miller ML; Ojima I
    Chem Rec; 2001; 1(3):195-211. PubMed ID: 11895119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
    Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
    Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
    Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
    Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition.
    Díaz JF; Andreu JM
    Biochemistry; 1993 Mar; 32(11):2747-55. PubMed ID: 8096151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3' and/or C-2 of taxotere (docetaxel).
    Ojima I; Duclos O; Zucco M; Bissery MC; Combeau C; Vrignaud P; Riou JF; Lavelle F
    J Med Chem; 1994 Aug; 37(16):2602-8. PubMed ID: 7914541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis.
    Carré M; Carles G; André N; Douillard S; Ciccolini J; Briand C; Braguer D
    Biochem Pharmacol; 2002 May; 63(10):1831-42. PubMed ID: 12034367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo.
    Shi B; Yaremko B; Hajian G; Terracina G; Bishop WR; Liu M; Nielsen LL
    Cancer Chemother Pharmacol; 2000; 46(5):387-93. PubMed ID: 11127943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
    Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
    Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells.
    Carles G; Braguer D; Sabeur G; Briand C
    Anticancer Drugs; 1998 Mar; 9(3):209-21. PubMed ID: 9625431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and SAR requirements of adamantane-colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities.
    Zefirova ON; Nurieva EV; Shishov DV; Baskin II; Fuchs F; Lemcke H; Schröder F; Weiss DG; Zefirov NS; Kuznetsov SA
    Bioorg Med Chem; 2011 Sep; 19(18):5529-38. PubMed ID: 21873068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
    Amaya C; Luo S; Baigorri J; Baucells R; Smith ER; Xu XX
    BMC Cancer; 2021 Sep; 21(1):981. PubMed ID: 34470602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.
    Budman DR; Calabro A
    Breast Cancer Res Treat; 2002 Jul; 74(1):41-6. PubMed ID: 12150451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antitumor activity of docetaxel.
    Eckardt JR
    Am J Health Syst Pharm; 1997 Dec; 54(24 Suppl 2):S2-6. PubMed ID: 9435925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microtubule inhibitory effects of various SJ compounds on tissue culture cells.
    Lee JH; Kang DW; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Paik SY; Lee JH
    Arch Pharm Res; 2004 Apr; 27(4):436-41. PubMed ID: 15180310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Natural anti-tumor compounds with activity of promoting microtubule assembly].
    Li YZ; Hu W; Zhou L
    Yao Xue Xue Bao; 2001 Feb; 36(2):155-60. PubMed ID: 12579888
    [No Abstract]   [Full Text] [Related]  

  • 59. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and evaluation of water-soluble non-prodrug analogs of docetaxel bearing sec-aminoethyl group at the C-10 position.
    Uoto K; Takenoshita H; Yoshino T; Hirota Y; Ando S; Mitsui I; Terasawa H; Soga T
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):770-6. PubMed ID: 9621410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.